Location History:
- Wurzburg, DE (1992)
- Würzburg, DE (2001 - 2004)
Company Filing History:
1 out of 1,164 
1 out of 155 
1 out of 832,843 Years Active: 1992-2004
Title: Friedrich Grummt: Innovator in Drug Delivery Systems
Introduction
Friedrich Grummt is a notable inventor based in Würzburg, Germany. He has made significant contributions to the field of drug delivery systems, holding a total of 3 patents. His work focuses on innovative methods to enhance the delivery of therapeutic molecules.
Latest Patents
Grummt's latest patents include groundbreaking inventions. One of his notable patents is for "Encapsulated cells containing an amplified expression vector as a drug delivery device." This invention provides a drug delivery device comprising encapsulated cells that contain multiple copies of an expression cassette. The device is designed to supply an animal, including humans, with therapeutically desirable molecules, addressing physiological activities lacking in disease conditions or acting as antagonists against various conditions.
Another significant patent is for an "Expression vector for the permanent expression of foreign DNA." This invention relates to an expression vector that includes foreign DNA, which has a sequence at its 3' end that prevents the replication of the expression vector from occurring in the opposite direction to the transcription. This invention is crucial for the permanent expression of foreign DNA in cells.
Career Highlights
Throughout his career, Grummt has worked with various organizations, including Boehringer Mannheim GmbH. His expertise in drug delivery systems has positioned him as a key figure in the field.
Collaborations
Grummt has collaborated with notable colleagues, including Birgitta Sauer and Martha Müller. Their combined efforts have contributed to advancements in the field of drug delivery and expression vectors.
Conclusion
Friedrich Grummt's innovative work in drug delivery systems and expression vectors has made a significant impact in the field of biotechnology. His patents reflect a commitment to improving therapeutic delivery methods, showcasing his role as a leading inventor in this area.